Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 101

1.

Stress doses of hydrocortisone in septic shock: beneficial effects on opsonization-dependent neutrophil functions.

Kaufmann I, Briegel J, Schliephake F, Hoelzl A, Chouker A, Hummel T, Schelling G, Thiel M.

Intensive Care Med. 2008 Feb;34(2):344-9. Epub 2007 Sep 29.

PMID:
17906853
2.

Stress doses of hydrocortisone reverse hyperdynamic septic shock: a prospective, randomized, double-blind, single-center study.

Briegel J, Forst H, Haller M, Schelling G, Kilger E, Kuprat G, Hemmer B, Hummel T, Lenhart A, Heyduck M, Stoll C, Peter K.

Crit Care Med. 1999 Apr;27(4):723-32.

PMID:
10321661
3.

Reversal of late septic shock with supraphysiologic doses of hydrocortisone.

Bollaert PE, Charpentier C, Levy B, Debouverie M, Audibert G, Larcan A.

Crit Care Med. 1998 Apr;26(4):645-50.

PMID:
9559600
4.

Immunologic and hemodynamic effects of "low-dose" hydrocortisone in septic shock: a double-blind, randomized, placebo-controlled, crossover study.

Keh D, Boehnke T, Weber-Cartens S, Schulz C, Ahlers O, Bercker S, Volk HD, Doecke WD, Falke KJ, Gerlach H.

Am J Respir Crit Care Med. 2003 Feb 15;167(4):512-20. Epub 2002 Nov 8.

PMID:
12426230
5.

Effect of stress doses of hydrocortisone on S-100B vs. interleukin-8 and polymorphonuclear elastase levels in human septic shock.

Mussack T, Briegel J, Schelling G, Biberthaler P, Jochum M.

Clin Chem Lab Med. 2005;43(3):259-68.

PMID:
15843228
6.

Effect of Hydrocortisone on Development of Shock Among Patients With Severe Sepsis: The HYPRESS Randomized Clinical Trial.

Keh D, Trips E, Marx G, Wirtz SP, Abduljawwad E, Bercker S, Bogatsch H, Briegel J, Engel C, Gerlach H, Goldmann A, Kuhn SO, Hüter L, Meier-Hellmann A, Nierhaus A, Kluge S, Lehmke J, Loeffler M, Oppert M, Resener K, Schädler D, Schuerholz T, Simon P, Weiler N, Weyland A, Reinhart K, Brunkhorst FM; SepNet–Critical Care Trials Group.

JAMA. 2016 Nov 1;316(17):1775-1785. doi: 10.1001/jama.2016.14799.

PMID:
27695824
7.

Effects of pentoxifylline on circulating cytokine concentrations and hemodynamics in patients with septic shock: results from a double-blind, randomized, placebo-controlled study.

Zeni F, Pain P, Vindimian M, Gay JP, Gery P, Bertrand M, Page Y, Page D, Vermesch R, Bertrand JC.

Crit Care Med. 1996 Feb;24(2):207-14.

PMID:
8605790
8.
9.

Does N-acetyl-L-cysteine influence cytokine response during early human septic shock?

Spapen H, Zhang H, Demanet C, Vleminckx W, Vincent JL, Huyghens L.

Chest. 1998 Jun;113(6):1616-24.

PMID:
9631802
10.

Polymorphonuclear leukocyte dysfunction syndrome in patients with increasing sepsis severity.

Kaufmann I, Hoelzl A, Schliephake F, Hummel T, Chouker A, Peter K, Thiel M.

Shock. 2006 Sep;26(3):254-61.

PMID:
16912650
11.

Low-dose hydrocortisone improves shock reversal and reduces cytokine levels in early hyperdynamic septic shock.

Oppert M, Schindler R, Husung C, Offermann K, Gräf KJ, Boenisch O, Barckow D, Frei U, Eckardt KU.

Crit Care Med. 2005 Nov;33(11):2457-64.

PMID:
16276166
12.

Effect of treatment with low doses of hydrocortisone and fludrocortisone on mortality in patients with septic shock.

Annane D, Sébille V, Charpentier C, Bollaert PE, François B, Korach JM, Capellier G, Cohen Y, Azoulay E, Troché G, Chaumet-Riffaud P, Bellissant E.

JAMA. 2002 Aug 21;288(7):862-71. Erratum in: JAMA. 2008 Oct 8;300(14):1652. Chaumet-Riffaut, Philippe [corrected to Chaumet-Riffaud, Philippe].

PMID:
12186604
13.

Effect of Early Vasopressin vs Norepinephrine on Kidney Failure in Patients With Septic Shock: The VANISH Randomized Clinical Trial.

Gordon AC, Mason AJ, Thirunavukkarasu N, Perkins GD, Cecconi M, Cepkova M, Pogson DG, Aya HD, Anjum A, Frazier GJ, Santhakumaran S, Ashby D, Brett SJ; VANISH Investigators.

JAMA. 2016 Aug 2;316(5):509-18. doi: 10.1001/jama.2016.10485.

PMID:
27483065
14.

Modulation of host defense by hydrocortisone in stress doses during endotoxemia.

Heller AR, Heller SC, Borkenstein A, Stehr SN, Koch T.

Intensive Care Med. 2003 Sep;29(9):1456-63. Epub 2003 Jul 17.

PMID:
12879235
15.

Cardiovascular effects of the nitric oxide synthase inhibitor NG-methyl-L-arginine hydrochloride (546C88) in patients with septic shock: results of a randomized, double-blind, placebo-controlled multicenter study (study no. 144-002).

Watson D, Grover R, Anzueto A, Lorente J, Smithies M, Bellomo R, Guntupalli K, Grossman S, Donaldson J, Le Gall JR; Glaxo Wellcome International Septic Shock Study Group.

Crit Care Med. 2004 Jan;32(1):13-20.

PMID:
14707555
16.
17.

[Effects of hydrocortisone on circulating and intramyocardial inflammatory mediators in severe septic rats with myocardial injury induced by Escherichia coli].

Wang YQ, Fan XM, Zhou T, Qi YJ, Chen H, Qian SY.

Zhonghua Er Ke Za Zhi. 2006 Feb;44(2):131-5. Chinese.

PMID:
16624031
18.

Time course of organ failure in patients with septic shock treated with hydrocortisone: results of the Corticus study.

Moreno R, Sprung CL, Annane D, Chevret S, Briegel J, Keh D, Singer M, Weiss YG, Payen D, Cuthbertson BH, Vincent JL.

Intensive Care Med. 2011 Nov;37(11):1765-72. doi: 10.1007/s00134-011-2334-x. Epub 2011 Aug 17.

PMID:
21847649
19.

Plasma cortisol levels before and during "low-dose" hydrocortisone therapy and their relationship to hemodynamic improvement in patients with septic shock.

Oppert M, Reinicke A, Gräf KJ, Barckow D, Frei U, Eckardt KU.

Intensive Care Med. 2000 Dec;26(12):1747-55.

PMID:
11271081
20.

Counteraction of early circulatory derangement by administration of low dose steroid treatment at the onset of established endotoxemic shock is not directly mediated by TNF-α and IL-6.

Söderberg E, Lipcsey M, Sjölin J, Larsson A, Eriksson MB.

Steroids. 2012 Sep;77(11):1101-6. doi: 10.1016/j.steroids.2012.06.001. Epub 2012 Jun 15.

PMID:
22705410

Supplemental Content

Support Center